IKZF1 and precursor B-cell acute lymphoblastic leukemia: Post-hoc analysis of the EORTC 58951 study revealed a significant improvement in DFS for children with IKZF1-deleted, Ph-negative B-ALL randomized to receive vincristine and steroid pulses during maintenance therapy [56].